Masimo’s long-running proxy fight has come to a close, at least for now. | Masimo’s long-running proxy fight has come to a ...

In a report released yesterday, Vik Chopra from Wells Fargo assigned a Buy rating to Masimo (MASI – Research Report), with a price target ...

Needham analyst Michael Matson maintained a Hold rating on Masimo (MASI – Research Report) today. The company’s shares opened today ...

Masimo shareholders today will decide on a bitter proxy fight between the company's founder and CEO Joe Kiani and Politan ...

which includes the Masimo W1 and the upcoming Masimo Freedom wearables, known for their precision in health monitoring. Qualcomm’s Snapdragon W5+ Gen 1 will power these next-gen devices ...

"We are united in our enthusiasm for Masimo’s future as a leading, innovation-focused growth company," the newest board ...

The powerhouse combination of Masimo’s clinically proven, breakthrough biosensing technologies – based on its decades of expertise designing industry-leading hospital monitoring solutions ...

--(BUSINESS WIRE)--Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive monitoring technologies and audio products, today is sharing a summary of ...

The deal results in Masimo, a company specializing in medical-grade health monitoring devices, offering a “reference platform” that other smartwatch manufacturers can use. This includes both ...

The powerhouse combination of Masimo’s clinically proven, breakthrough biosensing technologies – based on its decades of expertise designing industry-leading hospital monitoring solutions – and ...

Politan Capital Management said its candidates captured two board seats in Thursday’s shareholder vote, citing a preliminary analysis.